Home Cart Sign in  
Chemical Structure| 13626-60-3 Chemical Structure| 13626-60-3

Structure of 13626-60-3

Chemical Structure| 13626-60-3

3-Hydroxyisoxazole-5-carboxylic acid

CAS No.: 13626-60-3

4.5 *For Research Use Only !

Cat. No.: A155811 Purity: 97%

Change View

Size Price

US Stock

Global Stock

In Stock
250mg łËÿ¶ÊÊ Inquiry Inquiry
1g łÍʶÊÊ Inquiry Inquiry
5g łÇËÿ¶ÊÊ Inquiry Inquiry
25g łÍîÿ¶ÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • 250mg

    łËÿ¶ÊÊ

  • 1g

    łÍʶÊÊ

  • 5g

    łÇËÿ¶ÊÊ

  • 25g

    łÍîÿ¶ÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 13626-60-3 ]

CAS No. :13626-60-3
Formula : C4H3NO4
M.W : 129.07
SMILES Code : O=C(C1=CC(O)=NO1)O
MDL No. :MFCD08669892
InChI Key :VOCWBIGTEMMVGZ-UHFFFAOYSA-N
Pubchem ID :12369652

Safety of [ 13626-60-3 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 13626-60-3 ] Show Less

Physicochemical Properties

Num. heavy atoms 9
Num. arom. heavy atoms 5
Fraction Csp3 0.0
Num. rotatable bonds 1
Num. H-bond acceptors 5.0
Num. H-bond donors 2.0
Molar Refractivity 25.49
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

83.56 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.58
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.21
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.08
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.96
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.14
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

-0.05

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.12
Solubility 9.84 mg/ml ; 0.0763 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-1.52
Solubility 3.86 mg/ml ; 0.0299 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.0
Solubility 129.0 mg/ml ; 1.0 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.94 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

2.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.56

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.43
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 13626-60-3 ]

Alcohols

Chemical Structure| 14016-01-4

A290763 [14016-01-4]

3-Hydroxyisoxazole-5-carboxamide

Similarity: 0.80

Chemical Structure| 98019-60-4

A118729 [98019-60-4]

Isoxazol-5-ylmethanol

Similarity: 0.67

Chemical Structure| 123320-44-5

A139040 [123320-44-5]

(3-(Benzyloxy)isoxazol-5-yl)methanol

Similarity: 0.63

Chemical Structure| 25742-00-1

A246189 [25742-00-1]

(3-Bromoisoxazol-5-yl)methanol

Similarity: 0.55

Chemical Structure| 123770-62-7

A171141 [123770-62-7]

Ethyl 5-(hydroxymethyl)isoxazole-3-carboxylate

Similarity: 0.53

Carboxylic Acids

Chemical Structure| 21169-71-1

A107152 [21169-71-1]

Isoxazole-5-carboxylic acid

Similarity: 0.87

Chemical Structure| 261350-46-3

A177624 [261350-46-3]

4-Methylisoxazole-5-carboxylic acid

Similarity: 0.81

Chemical Structure| 2552-54-7

A508231 [2552-54-7]

3-(Benzyloxy)isoxazole-5-carboxylic acid

Similarity: 0.77

Chemical Structure| 4857-42-5

A391806 [4857-42-5]

3-Methylisoxazole-5-carboxylic acid

Similarity: 0.77

Chemical Structure| 6567-35-7

A520946 [6567-35-7]

3-Bromoisoxazole-5-carboxylic acid

Similarity: 0.72

Related Parent Nucleus of
[ 13626-60-3 ]

Isoxazoles

Chemical Structure| 21169-71-1

A107152 [21169-71-1]

Isoxazole-5-carboxylic acid

Similarity: 0.87

Chemical Structure| 261350-46-3

A177624 [261350-46-3]

4-Methylisoxazole-5-carboxylic acid

Similarity: 0.81

Chemical Structure| 14016-01-4

A290763 [14016-01-4]

3-Hydroxyisoxazole-5-carboxamide

Similarity: 0.80

Chemical Structure| 173850-41-4

A224155 [173850-41-4]

Ethyl isoxazole-5-carboxylate

Similarity: 0.80

Chemical Structure| 2552-54-7

A508231 [2552-54-7]

3-(Benzyloxy)isoxazole-5-carboxylic acid

Similarity: 0.77